✦ LIBER ✦

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

✍ Scribed by Antonio Palumbo; Sara Bringhen; Tommaso Caravita; Emanuela Merla; Vincenzo Capparella; Vincenzo Callea; Clotilde Cangialosi; Mariella Grasso; Fausto Rossini; Monica Galli; Lucio Catalano; Elena Zamagni; Maria Teresa Petrucci; Valerio De Stefano; Manuela Ceccarelli; Maria Teresa Ambrosini; Ilaria Avonto; Patrizia Falco; Giovannino Ciccone; Anna Marina Liberati; Pellegrino Musto; Mario Boccadoro

Book ID: 117298906
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 114 KB
Volume: 367
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(06)68338-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melphalan and prednisone plus thalidomid

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

✍ Thierry Facon; Jean Yves Mary; Cyrille Hulin; Lotfi Benboubker; Michel Attal; Br 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB

PSY32 THALIDOMIDE PLUS MELPHALAN AND PRE

PSY32 THALIDOMIDE PLUS MELPHALAN AND PREDNISONE FOR AUSTRALIAN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA IS COST-EFFECTIVE WHEN COMPARED WITH MELPHALAN AND PREDNISONE ALONE

✍ R De Abreu Lourenco; S Colman; C Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Melphalan and prednisone versus melphala

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

✍ Kapoor, P; Rajkumar, S V; Dispenzieri, A; Gertz, M A; Lacy, M Q; Dingli, D; Mikh 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 408 KB

Melphalan/prednisone versus melphalan/pr

Melphalan/prednisone versus melphalan/prednisone plus human alpha interferon therapy in patients with multiple myeloma, stages II and III

✍ Magnus Björkholm 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 199 KB

Bortezomib, melphalan, and prednisone ve

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

✍ María-Victoria Mateos; Albert Oriol; Joaquín Martínez-López; Norma Gutiérrez; An 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 255 KB

MELPHALAN-PREDNISONE-THALIDOMIDE (MP-T)

MELPHALAN-PREDNISONE-THALIDOMIDE (MP-T) DEMONSTRATES A SIGNIFICANT SURVIVAL ADVANTAGE IN ELDERLY PATIENTS >75 YEARS WITH MULTIPLE MYELOMA COMPARED WITH MELPHALAN-PREDNISONE (MP) IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, IFM01/01

✍ C. Hulin; O. Decaux; V. Coiteux; P. Rodon; B. Pegourie; L. Benboubker; L. Gagneu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB